How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer's disease

2021 ◽  
Vol 17 (6) ◽  
pp. 917-919
Author(s):  
Anna G. M. Temp ◽  
Michael W. Lutz ◽  
Dominic Trepel ◽  
Yi Tang ◽  
Eric‐Jan Wagenmakers ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Research ◽  
Bayesian Statistics

Constructing a Local Potential Participant Registry to Improve Alzheimer’s Disease Clinical Research Recruitment

2018 ◽  
Vol 63 (3) ◽  
pp. 1055-1063 ◽  
Author(s):  
Joshua D. Grill ◽  
Dan Hoang ◽  
Daniel L. Gillen ◽  
Chelsea G. Cox ◽  
Adrijana Gombosev ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Research ◽  
Local Potential ◽  
Potential Participant ◽  
Research Recruitment

scholarly journals Reduced memory and executive functioning significantly relates to participation in early phase clinical research in Alzheimer's disease

2020 ◽  
Vol 16 (S9) ◽  
Author(s):  
Lovingly Park ◽  
Lev Gertsik ◽  
Zyanya Mendoza ◽  
Lydia Morris ◽  
Claudia Aguilar ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Executive Functioning ◽  
Clinical Research ◽  
Early Phase

Magnetic Resonance Imaging Based Clinical Research in Alzheimer's Disease

2012 ◽  
Vol 31 (s3) ◽  
pp. S5-S18 ◽  
Author(s):  
Nicolás Fayed ◽  
Pedro J. Modrego ◽  
Gulillermo Rojas Salinas ◽  
José Gazulla
Keyword(s):  
Magnetic Resonance Imaging ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Magnetic Resonance ◽  
Clinical Research ◽  
Resonance Imaging

scholarly journals Biomarkers in Mild Stages of Alzheimer’s disease: Utility in clinical practice and their relation with nutritional and lifestyle factors

2016 ◽  
Vol 6 (10) ◽  
pp. 627
Author(s):  
Carol Dillon ◽  
Patricio Pérez Leguizamon ◽  
Silvina Heisecke ◽  
Diego M. Castro ◽  
Jorge Lopez Camelo ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trials ◽  
Clinical Practice ◽  
Clinical Research ◽  
Lifestyle Factors ◽  
Clinical Settings ◽  
Treatment Methods ◽  
Primary Endpoints ◽  
Alzheimer’S Disease Dementia

Background: The use of biomarkers in basic and clinical research as well as in clinical practice has become so common that their presence as primary endpoints in clinical trials is now accepted. A biomarker refers to a broad subcategory of medical signs. The aims of this article are to consider the of use biomarkers in Mild stages of Alzheimer’s disease (AD) in research and clinical settings, in addition to defining their utility in clinical practice relating this with nutritional and lifestyle factors as possible treatment. Methods: We searched MEDLINE, PubMed, and AgeLine databases using different keywords.Conclusions: A summary of the utility of biomarkers in AD and nutritional and lifestyle factors used as treatment in mild stages are described.Key words: Biomarkers, Alzheimer’s disease, Dementia, Utility, Clinical practice, Nutritional

Sign in / Sign up

Export Citation Format

Share Document